Quarterly report pursuant to Section 13 or 15(d)

Sponsored Research and Clinical Trial Agreements (Narrative) (Details)

v3.21.2
Sponsored Research and Clinical Trial Agreements (Narrative) (Details)
1 Months Ended 3 Months Ended 6 Months Ended
Jul. 01, 2020
USD ($)
Oct. 31, 2020
USD ($)
Sep. 30, 2020
USD ($)
May 31, 2020
USD ($)
Feb. 28, 2017
USD ($)
Mar. 31, 2015
USD ($)
installment
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Nov. 30, 2020
USD ($)
Jul. 03, 2017
USD ($)
Research and development             $ 22,831,000 $ 15,703,000 $ 42,859,000 $ 30,570,000    
Research and Clinical Trial Agreements [Member] | Aevitas [Member]                        
Research and development             24,000   272,000 281,000    
Research and Clinical Trial Agreements [Member] | Aevitas [Member] | University of Massachusetts [Member]                        
Research and development             24,000   272,000 0    
Research and Clinical Trial Agreements [Member] | Aevitas [Member] | University of Pennsylvania [Member]                        
Research and development                 0 281,000    
Research and Clinical Trial Agreements [Member] | Mustang [Member]                        
Research and development             1,260,000 2,816,000 3,102,000 4,166,000    
Research and Clinical Trial Agreements [Member] | Mustang [Member] | City of Hope (COH) [Member]                        
Research and development                 0 500,000    
Research and Clinical Trial Agreements [Member] | Mustang [Member] | City of Hope (COH) [Member] | MB-102 (CD 123 CAR T for AML) [Member]                        
Research and development             21,000 65,000 226,000 296,000    
Research and Clinical Trial Agreements [Member] | Mustang [Member] | City of Hope (COH) [Member] | MB-104 (CS1 CAR T) [Member]                        
Research and development             197,000 770,000 372,000 770,000    
Research and Clinical Trial Agreements [Member] | Mustang [Member] | City of Hope (COH) [Member] | MB-101 (IL13R2 CAR T for Glioblastoma) [Member]                        
Research and development             279,000 234,000 793,000 326,000    
Sponsored research agreement, funding commitment           $ 2,000,000.0            
Number of installments to pay the upfront fees | installment           4            
Research and Clinical Trial Agreements [Member] | Mustang [Member] | City of Hope (COH) [Member] | MB-103 (HER2 CAR T) [Member]                        
Research and development             31,000   154,000 0    
Research and Clinical Trial Agreements [Member] | Mustang [Member] | City of Hope (COH) [Member] | MB-105 (PSCA CAR T) [Member]                        
Research and development                 46,000 0    
Research and Clinical Trial Agreements [Member] | Mustang [Member] | Fred Hutchinson Cancer Research Center [Member] | MB-106 (CD20 CAR T) [Member]                        
Research and development             327,000 189,000 998,000 716,000    
Research and Clinical Trial Agreements [Member] | Mustang [Member] | St. Jude Children's Research Hospital [Member] | MB-107 (XSCID) [Member]                        
Research and development             176,000 1,558,000 280,000 1,558,000    
Research and Clinical Trial Agreements [Member] | Mustang [Member] | Mayo Clinic [Member]                        
Research and development             233,000   233,000 0    
Research and Clinical Trial Agreements [Member] | Oncogenuity [Member]                        
Research and development             348,000 125,000 671,000 125,000    
Research and Clinical Trial Agreements [Member] | Oncogenuity [Member] | Columbia University [Member]                        
Research and development             187,000 125,000 375,000 125,000    
Funding commitment period       5 years                
Research and Clinical Trial Agreements [Member] | Oncogenuity [Member] | University of California [Member]                        
Research and development             66,000 0 122,000 0    
Research and Clinical Trial Agreements [Member] | Oncogenuity [Member] | University of Oxford [Member]                        
Research and development             95,000 0 174,000 0    
Research and Clinical Trial Agreements [Member] | Oncogenuity [Member] | Maximum [Member] | Columbia University [Member]                        
Sponsored research agreement, funding commitment       $ 4,800,000                
Sponsored Research Agreement [Member] | Mustang [Member] | City of Hope (COH) [Member]                        
Research and development                 0 500,000    
Clinical Trial Agreements [Member] | Mustang [Member] | City of Hope (COH) [Member] | MB-102 (CD 123 CAR T for AML) [Member]                        
Research and development             100,000 100,000 200,000 300,000    
Upfront fees payment         $ 19,450              
Sponsored research agreement, funding commitment         $ 200,000              
Funding commitment period         3 years              
Sponsored research agreement, additional funding commitment         $ 97,490              
Clinical Trial Agreements [Member] | Mustang [Member] | City of Hope (COH) [Member] | MB-104 (CS1 CAR T) [Member]                        
Research and development             200,000 800,000 400,000 800,000    
Upfront fees payment                   800,000    
Clinical Trial Agreements [Member] | Mustang [Member] | City of Hope (COH) [Member] | MB-101 (IL13R2 CAR T for Glioblastoma) [Member]                        
Research and development             300,000 200,000 800,000 300,000    
Upfront fees payment   $ 29,000     9,300              
Payments of milestones         $ 100,000              
Sponsored research agreement, funding commitment   100,000         200,000   200,000      
Funding commitment period         3 years              
Sponsored research agreement, additional funding commitment   200,000     $ 200,000              
Clinical Trial Agreements [Member] | Mustang [Member] | City of Hope (COH) [Member] | MB-103 (HER2 CAR T) [Member]                        
Research and development             0.0   100,000      
Upfront fees payment     $ 29,375                  
Clinical Trial Agreements [Member] | Mustang [Member] | City of Hope (COH) [Member] | MB-105 (PSCA CAR T) [Member]                        
Research and development                 100,000 0    
Upfront fees payment   33,000                    
Sponsored research agreement, funding commitment   $ 2,300,000                    
Clinical Trial Agreements [Member] | Mustang [Member] | Fred Hutchinson Cancer Research Center [Member] | MB-106 (CD20 CAR T) [Member]                        
Research and development             300,000 200,000 1,000,000.0 700,000    
Sponsored research agreement, funding commitment                       $ 5,300,000
Sponsored research agreement, additional funding commitment                     $ 800,000  
Clinical Trial Agreements [Member] | Mustang [Member] | St. Jude Children's Research Hospital [Member] | MB-107 (XSCID) [Member]                        
Research and development             200,000 1,600,000 300,000 1,600,000    
Upfront fees payment $ 1,100,000                      
Clinical Trial Agreements [Member] | Mustang [Member] | Mayo Clinic [Member]                        
Research and development             200,000   200,000      
Sponsored research agreement, funding commitment             $ 2,100,000   $ 2,100,000      
Funding commitment period                 2 years      
Clinical Trial Agreements [Member] | Mustang [Member] | Maximum [Member] | City of Hope (COH) [Member] | MB-104 (CS1 CAR T) [Member]                        
Sponsored research agreement, funding commitment               $ 2,400,000   $ 2,400,000    
Clinical Trial Agreements [Member] | Mustang [Member] | Maximum [Member] | City of Hope (COH) [Member] | MB-103 (HER2 CAR T) [Member]                        
Sponsored research agreement, funding commitment     $ 3,000,000.0